Healthcare ❯ Public Health

Screening Programs

Prostate Cancer Screening NHS Prostate Cancer Cancer Screening Access to Care Community Health Newborn Screening Mammography Cancer Detection Inequities

Cochrane Review Finds PSA Screening Modestly Cuts Prostate Cancer Deaths

The finding renews pressure on UK health bodies to revisit guidance on offering PSA tests.

Bowel Cancer Screening Uptake in England Stalls at 71% With Sharp Regional Gaps

Early-Onset Colon Cancer Rises in Argentina as Galicia’s Screening Finds More Tumors Early

UK Prostate Cancer Screening Trial Starts With First Men Tested

Study Finds Prostate Screening Can Match Mammography on Key Measures, With Trade‑Offs

Early-Onset Colorectal Cancer Surges, Prompting Fresh Calls for Screening at 45

Lung Cancer Tops Deaths in Rhineland-Palatinate as Vorarlberg Sees Falling Mortality

Prostate Cancer Now the UK’s Most Common Cancer as Screening Policy Faces Review

Jesy Nelson’s Partner Condemns UK Delay on Newborn SMA Screening as Pressure Builds for £5 Test

UK Screening Advisers Advise Against Routine PSA Testing in Draft Decision

UK Panel Rejects Mass Prostate Screening, Backs Targeted Checks for BRCA Carriers

After NSC Rejects Routine Prostate Screening, Colin McFarlane Urges Black Men to Get Tested

UK Launches £42m Transform Trial to Compare Prostate Cancer Screening Options

Lung Cancer Survival Climbs With Earlier Detection as ALA Flags Threats to Progress

23-Year Trial Finds PSA Screening Cuts Prostate Cancer Deaths as UK Review Nears

ICR Urges Annual PSA Testing for BRCA Men After Trial Shows Higher, Earlier Prostate Cancer Risk

UK Panel Expected to Oppose National Prostate Screening as Campaigners Unveil New Cost Model

Dermot Murnaghan Urges PSA Testing as He Updates Stage-Four Prostate Cancer Recovery

Cervical Cancer Rates Nearly Double in US Counties With Persistently Low Screening

Canada’s Prostate Screening Guidance on Hold as UK Review Targets High-Risk Tests